NVIDIA reported Q2 fiscal 2027 results on August 19, and the stock's first reaction is a 2.3% pullback to $219.74 — a modest decline that follows a pattern bears have been unable to exploit all summer.
The post-earnings dip has done nothing to disturb what has been a structurally quiet short base. Short interest ticked down slightly to 1.21% of free float — essentially flat on the week and sitting near a three-month low. The broader retreat from the 1.44–1.46% band that held through most of July is now confirmed: bears covered into earnings and did not press back in. Borrow conditions give them no particular incentive to change that stance. Cost to borrow has eased to 0.21%, and availability remains entirely unconstrained — the lending pool is loose by any measure. There is no mechanical squeeze dynamic here, and no sign of a fresh short thesis gaining traction in the lending market.
Options positioning tells a similarly composed story. The put/call ratio dipped to 0.81 on Tuesday — slightly below its 20-day average of 0.84 and roughly 0.8 standard deviations below the mean. That is a mild call skew, not an aggressive one. The 52-week range runs from 0.70 to 1.02, placing current positioning near the middle. The market was not pricing in an extreme outcome in either direction heading into the print, and the light 2% sell-off suggests that view was roughly correct. Peers have been weaker: dropped 3.2% on the day and fell 8.7% on the week, while and both shed over 9% Tuesday alone. NVIDIA's relative outperformance on the day is worth noting.
The Street remains firmly in one camp. All 48 analysts tracked carry buy-equivalent ratings, with the consensus price target implying roughly 35% upside from current levels. The most recent action — Wells Fargo reiterating Overweight with a $315 target on August 11 — came before the print and hasn't moved. Targets across the coverage universe cluster in a wide band from $270 (Needham) to $425 (Tigress Financial), with the more measured targets from UBS ($280) and Truist ($307) likely reflecting valuation discipline rather than fundamental doubt. At a trailing P/E near 19.8x and P/B of 12.2x, the multiple has expanded modestly over the past month but remains well below the peaks this stock has traded at during prior AI-enthusiasm cycles. EV/EBITDA at 15.9x has actually contracted slightly over the past 30 days, suggesting the earnings run-rate is expanding faster than the share price.
The earnings history adds context the options market appeared to have absorbed. The last three post-earnings sessions all produced negative one-day reactions — down 2.1% in June, down 3.6% in May, and down 0.5% in the fiscal Q1 print. The five-day drift after each event was also negative, ranging from -1.2% to -4.1%. Tuesday's 2.3% reaction lands squarely within that established range. The pattern suggests NVIDIA has spent the better part of 2026 beating estimates but failing to produce the positive surprise magnitude needed to move the stock higher on print day, against a backdrop of already-elevated expectations.
The OpenAI commitment announced Monday — roughly $600 billion in NVIDIA compute through 2030 — is the structural variable that doesn't fit neatly into the historical earnings-reaction template. That announcement was in the market before the print. How management frames the revenue cadence from that agreement on the call, and whether Q3 guidance reflects any acceleration from large-scale AI factory deployments, is what the 35%-upside thesis ultimately rests on. The short score of 29.4 — low and stable — and the factor ranking of 85th percentile on analyst recommendation divergence confirm there is no meaningful bearish institutional consensus forming. The conversation now shifts from "will NVIDIA beat?" to whether the order-book visibility from AI infrastructure commitments justifies the current premium.
See the live data behind this article on ORTEX.
Open NVDA on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
